The selective norepinephrine reuptake inhibitor reboxetine promotes late-stage fracture healing in mice

Impaired fracture healing is of high clinical relevance, as up to 15% of patients with long-bone fractures display non-unions. Fracture patients also include individuals treated with selective norepinephrine reuptake inhibitors (SNRI). As SNRI were previously shown to negatively affect bone homeosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Donat, Antonia, Jiang, Shan, Xie, Weixin, Knapstein, Paul Richard, Albertsen, Lilly-Charlotte, Kokot, Judith Luisa, Sevecke, Jan, Augustin, Ruben, Jahn, Denise, Yorgan, Timur Alexander, Frosch, Karl-Heinz, Tsitsilonis, Serafeim, Baranowsky, Anke, Keller, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504537/
https://www.ncbi.nlm.nih.gov/pubmed/37720081
http://dx.doi.org/10.1016/j.isci.2023.107761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504537/
https://www.ncbi.nlm.nih.gov/pubmed/37720081
http://dx.doi.org/10.1016/j.isci.2023.107761

Ejemplares similares